http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID130613_PMID3625714

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103168984_AID130613_PMID3625714_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103336466_AID130613_PMID3625714_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103210760_AID130613_PMID3625714_VALUE2
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103730720_AID130613_PMID3625714_VALUE4
has participant http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10090
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title The compound was tested in vitro for antitumor activity(50% inhibition of tumor cell growth) against the P388/doxorubicin resistant murine cell lines after 72 hours
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103210760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103336466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103730720
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103168984
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID130613

Total number of triples: 13.